FDA Drug Recalls

Recalls / Class II

Class IID-0479-2025

Product

Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Affected lot / code info
Lot #: H270221, Exp 12/26/2025

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
88 Inverness Cir E Unit A204, Englewood, Colorado 80112-5521

Distribution

Quantity
32 syringes
Distribution pattern
USA Nationwide

Timeline

Recall initiated
2025-05-21
FDA classified
2025-06-20
Posted by FDA
2025-07-02
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0479-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls